HeartFlow's chief medical officer exercised 67,017 options and sold 64,533 common shares on March 19, 2026, generating approximately $1.66 million in proceeds at an average price of about $25.69 per share. This appears to be a routine insider liquidity event and is unlikely to materially affect the company's fundamentals.
HeartFlow's chief medical officer exercised 67,017 options and sold 64,533 common shares on March 19, 2026, generating approximately $1.66 million in proceeds at an average price of about $25.69 per share. This appears to be a routine insider liquidity event and is unlikely to materially affect the company's fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
